Patients With Gout Likely To Develop CKD, Kidney Stones
the Clinical Pain Advisor take:
Gout may predispose patients to chronic kidney disease (CKD) and nephrolithiasis, suggests a new meta-analysis published in Arthritis Research and Therapy.
Investigators pooled results from 17 epidemiological studies of gout patients. Estimates of CKD (stage 3 and above) and nephrolithiasis among people with gout were 24% and 14%, respectively.
In addition, gout was linked with more than twice the odds of developing CKD and one and a half times the odds of ever developing nephrolithiasis. Few of the included studies were prospective, so the researchers couldn't assess timing.
According to the researchers, patients with gout should actively be screened for CKD and its related conditions. Currently, just 1 in 5 patients with acute gout are screened for CKD within a month of presentation.
There are several possible mechanisms by which gout could lead to CKD and kidney stones, they noted. Kidney damage may result from hypertension, diabetes, nonsteroidal anti-inflammatory drugs, and endothelial dysfunction from hyperuricemia. Or, persistent inflammation from gout may cause vascular damage.
Treatment with allopurinol was believed to interfere with kidney function, but a recent systematic review suggested that it actually may protect against CKD progression.
Associations between gout and renal disease and nephrolithiasis have long been recognized.
Associations between gout and renal disease and nephrolithiasis have long been recognised, yet early studies undertaken in specialist secondary care populations are likely to be unrepresentative of most patients with gout who are managed exclusively in primary care settings. To the best of our knowledge, no previous systematic reviews examining this association have been performed.
Clinical Pain Advisor Articles
- Abuse-Deterrent Opioid Formulations: Barriers to Broader Use
- Women Frequently Prescribed High Doses of Opioids After Vaginal Delivery
- Notifications by PDMPs May Not Effectively Reduce Opioid Misuse
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Medical Cannabis Legalization Associated With Reduced Schedule III Opioid Prescriptions
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- Opioid Use Disorder Prevalence at Delivery on the Rise in the US, According to CDC
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Pharmacologically Induced Headache Accompanied by Dilated Cephalic Vessels
- IV Lidocaine May Be Safe, Efficacious for Pediatric Status Migraine
- Gray Matter Changes in Migraine Associated With Clinical Characteristics